González-Fuentes Joaquin, Selva Jorge, Moya Carmen, Castro-Vázquez Lucia, Lozano Maria V, Marcos Pilar, Plaza-Oliver Maria, Rodríguez-Robledo Virginia, Santander-Ortega Manuel J, Villaseca-González Noemi, Arroyo-Jimenez Maria M
Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System, Faculty of Pharmacy and Faculty of Medicine, University of Castilla-La Mancha, CRIB (Regional Centre of Biomedical Research), Albacete, Spain.
Front Neurosci. 2018 Oct 23;12:721. doi: 10.3389/fnins.2018.00721. eCollection 2018.
The prevalence of neurodegenerative disorders is increasing; however, an effective neuroprotective treatment is still remaining. Nutrition plays an important role in neuroprotection as recently shown by epidemiological and biochemical studies which identified food components as promising therapeutic agents. Neuroprotection includes mechanisms such as activation of specific receptors, changes in enzymatic neuronal activity, and synthesis and secretion of different bioactive molecules. All these mechanisms are focused on preventing neuronal damage and alleviating the consequences of massive cell loss. Some neuropathological disorders selectively affect to particular neuronal populations, thus is important to know their neurochemical and anatomical properties in order to design effective therapies. Although the design of such treatments would be specific to neuronal groups sensible to damage, the effect would have an impact in the whole nervous system. The difficult overcoming of the blood brain barrier has hampered the development of efficient therapies for prevention or protection. This structure is a physical, enzymatic, and influx barrier that efficiently protects the brain from exogenous molecules. Therefore, the development of new strategies, like nanocarriers, that help to promote the access of neuroprotective molecules to the brain, is needed for providing more effective therapies for the disorders of the central nervous system (CNS). In order both to trace the success of these nanoplatforms on the release of the bioactive cargo in the CNS and determinate the concentration at trace levels of targets biomolecules by analytical chemistry and concretely separation instrumental techniques, constitute an essential tool. Currently, these techniques are used for the determination and identification of natural neuroprotective molecules in complex matrixes at different concentration levels. Separation techniques such as chromatography and capillary electrophoresis (CE), using optical and/or mass spectrometry (MS) detectors, provide multiples combinations for the quantitative and qualitative analysis at basal levels or higher concentrations of bioactive analytes in biological samples. Bearing this in mind, the development of food neuroprotective molecules as brain therapeutic agents is a complex task that requires the intimate collaboration and engagement of different disciplines for a successful outcome. In this sense, this work reviews the new advances achieved in the area toward a better understanding of the current state of the art and highlights promising approaches for brain neuroprotection.
神经退行性疾病的患病率正在上升;然而,一种有效的神经保护治疗方法仍有待探索。营养在神经保护中起着重要作用,最近的流行病学和生化研究表明,食物成分有望成为治疗药物。神经保护包括激活特定受体、改变神经元酶活性以及合成和分泌不同生物活性分子等机制。所有这些机制都致力于预防神经元损伤并减轻大量细胞损失的后果。一些神经病理疾病会选择性地影响特定的神经元群体,因此了解它们的神经化学和解剖学特性对于设计有效的治疗方法很重要。尽管此类治疗方法的设计将针对易受损的神经元群体,但效果将对整个神经系统产生影响。血脑屏障难以突破,这阻碍了预防或保护有效疗法的开发。这种结构是一种物理、酶促和流入屏障,可有效保护大脑免受外源分子的侵害。因此,需要开发新的策略,如纳米载体,以帮助促进神经保护分子进入大脑,从而为中枢神经系统(CNS)疾病提供更有效的治疗方法。为了追踪这些纳米平台在中枢神经系统中生物活性物质释放方面的成功情况,并通过分析化学,特别是分离仪器技术确定目标生物分子痕量水平的浓度,这构成了一项必不可少的工具。目前,这些技术用于测定和鉴定复杂基质中不同浓度水平的天然神经保护分子。诸如色谱法和毛细管电泳(CE)等分离技术,使用光学和/或质谱(MS)检测器,为生物样品中基础水平或更高浓度的生物活性分析物的定量和定性分析提供了多种组合。考虑到这一点,将食物中的神经保护分子开发为脑治疗剂是一项复杂的任务,需要不同学科密切合作并共同努力才能取得成功。从这个意义上说,这项工作回顾了该领域取得的新进展,以更好地了解当前的技术水平,并突出了脑神经保护的有前景的方法。